Impact of cholemic nephrosis on renal failure in cirrhotic patients

Impact of cholemic nephrosis on renal failure in cirrhotic patients

Introduction and Objectives: : The development of acute kidney injury (AKI) in cirrhotic patients is of multifactorial origin, including urinary tract infection, diuretics, portal hypertension, shock, etc. Another important factor is cholemic nephrosis, it is considered when total bilirubin exceeds...

Full description

Bibliographic Details
Main Authors:	Silvia J. Lozada-Calle, Angel D. Santana-Vargas, María F. Higuera-de la Tijera, Christian Calderón-Mendoza, Carlos Barragán-Pasten, Ricardo García-Peniche, Vilma Hernández-Garza, José L. Pérez-Hernández
Format:	Article
Language:	English
Published:	Elsevier 2024-02-01
Series:	Annals of Hepatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268124002382

Similar Items

Cholemic Nephrosis: An Autopsy Study of a Forgotten Entity
by: Valli PRIYAA, et al.
Published: (2021-09-01)

Cholemic Nephropathy: Hyperbilirubinemia and its Impact on Renal Function
by: Jonathan S Chávez-Iñiguez, et al.
Published: (2019-03-01)

Correlation between steatosis and fibrosis in patients with metabolic syndrome
by: Leonardo S. Juárez-Chavez, et al.
Published: (2024-02-01)

Validation of S-ANT for the diagnosis of minimal hepatic encephalopathy
by: Ángel D. Santana-Vargas, et al.
Published: (2024-02-01)

Lipoprotein metabolism in experimental nephrosis
by: J B Marsh
Published: (1984-12-01)

Effects of Dietary Salt Restriction on Renal Progression and Interstitial Fibrosis in Adriamycin Nephrosis
by: Joon-Sung Park, et al.
Published: (2014-07-01)

Cholemic Nephropathy as Cause of Acute and Chronic Kidney Disease. Update on an Under-Diagnosed Disease
by: Francesca Tinti, et al.
Published: (2021-11-01)

P-65 NOREPINEPHRINE INFUSION AS AN ALTERNATIVE TO ALBUMIN POST LARGE VOLUMEN PARACENTESIS IN CIRRHOTIC PATIENTS
by: Ernaldo Morales-Mairena, et al.
Published: (2023-03-01)

Proinflammatory role of angiotensin II in a rat nephrosis model induced by adriamycin
by: Maydelin Muñoz, et al.
Published: (2011-12-01)

Effects of dietary salt restriction on puromycin aminonucleoside nephrosis
by: Chor Ho Jo, et al.
Published: (2012-06-01)

Severe hypothyroidism associated with the degree of edema in a patient with nephrosis
by: Hiroyuki Kinoshita, et al.
Published: (2011-10-01)

Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosis
by: Willemijn AKM Windt, et al.
Published: (2004-12-01)

CAUSES OF DECOMPENSATION IN HOSPITALIZED CIRRHOTIC PATIENTS
by: A.B. Moreno-Cobos, et al.
Published: (2022-01-01)

Congenital hepatic fibrosis as a rare cause of non-cirrhotic portal hypertension
by: MO Santana Montes, et al.
Published: (2022-12-01)

Infantile nephropathic cystinosis with incomplete fanconi syndrome, hypothyroidism, hydro-uretero-nephrosis, and megacystis
by: Vaishali More, et al.
Published: (2016-01-01)

Overexpression of human apolipoprotein A-I in transgenic rats and the hyperlipoproteinemia associated with experimental nephrosis
by: B F Burkey, et al.
Published: (1995-07-01)

TRPC5 Channel Inhibition Protects Podocytes in Puromycin-Aminonucleoside Induced Nephrosis Models
by: Yiming Zhou, et al.
Published: (2021-09-01)

PORTA VEIN THROMBOSIS (PVT) IN CIRRHOTIC PATIENTS PRE AND DURING THE PANDEMIC BY SARS-COV2
by: C.A. Campoverde-Espinoza, et al.
Published: (2022-01-01)

Septic Shock, Renal Abscess, and Bacteremia Due to Peptoniphilus asaccharolyticus in a Woman with Nephrosis and Diabetes Mellitus: Case Report and Literature Review
by: Lu Y, et al.
Published: (2022-03-01)

PREVALENCE AND CHARACTERISTICS OF PORTAL VEIN RECANALIZATION IN CIRRHOTIC PATIENTS ADMITTED WITH PORTAL THROMBOSIS IN A THIRD LEVEL CARE CENTER
by: C.A. Campoverde-Espinoza, et al.
Published: (2022-01-01)

Hepatocelullar carcinoma is a major risk factor for the development of portal ven thrombosis in cirrhotic patients
by: C.A. Espinoza, et al.
Published: (2020-09-01)

<i>Aspergillus</i> Section <i>Fumigati</i> Pneumonia and Oxalate Nephrosis in a Foal
by: Jasmine Hattab, et al.
Published: (2021-08-01)

Pharmacological Melanocortin 5 Receptor Activation Attenuates Glomerular Injury and Proteinuria in Rats with Puromycin Aminonucleoside Nephrosis
by: Bohan Chen
Published: (2023-05-01)

Pharmacological Melanocortin 5 Receptor Activation Attenuates Glomerular Injury and Proteinuria in Rats With Puromycin Aminonucleoside Nephrosis
by: Bohan Chen, et al.
Published: (2022-06-01)

Prevalence and characteristics of cirrhotic patients with portal vein thrombosis admited in the Gastroenterology Department of the Hospital General de Mexico
by: C.A. Campoverde-Espinoza, et al.
Published: (2020-09-01)

Nephrosis as a paraneoplastic syndrome in the course of Hodgkin’s lymphoma in a 13-year-old boy – case report
by: Maciej Walczak
Published: (2019-06-01)

Haemodynamic effects of plasma-expansion with hyperoncotic albumin in cirrhotic patients with renal failure: a prospective interventional study
by: Huber Wolfgang, et al.
Published: (2008-08-01)

Protein energy-wasting associated with nephrotic syndrome – the comparison of metabolic pattern in severe nephrosis to different stages of chronic kidney disease
by: Anna Matyjek, et al.
Published: (2020-08-01)

Unveiling a pseudoaneurysm at the anastomosis site in a transplanted kidney: An initial misclassification as hydro nephrosis - A case report and literature review
by: Niki Tadayon, et al.
Published: (2023-09-01)

SERUM DETERMINATION OF MMP-2 AND MMP-9 ACCORDING TO THE PATTERN OF ALCOHOL CONSUMPTION AND IN ALCOHOLIC HEPATIC DISEASE
by: A. Hernandez-Barragan, et al.
Published: (2022-01-01)

Early predictors of renal dysfunction in cirrhotic patients after liver transplantation
by: Federico Piñero, et al.
Published: (2014-01-01)

Systemic hemodynamic and renal effects of midodrine and octreotide in cirrhotic patients with ascites
by: Georgios N Kalambokis, et al.
Published: (2011-01-01)

Cirrhotic cardiomyopathy: An independent prognostic factor for cirrhotic patients
by: Yun Bin Lee, et al.
Published: (2018-12-01)

Cirrhotic Cardiomyopathy
by: Kieran Longley, et al.
Published: (2021-02-01)

Cirrhotic cardiomyopathy
by: Fouad Tamer R, et al.
Published: (2007-03-01)

P-115 SUSCEPTIBILITY TO LIVER DAMAGE IN WOMEN DUE TO RISKY ALCOHOL CONSUMPTION.
by: José Luis Pérez-Hernández, et al.
Published: (2023-03-01)

Comparison of the meld-la model as a predictor of early mortality in Mexican patients with chronic decompensated liver disease
by: A Enríquez-Constantino, et al.
Published: (2022-12-01)

Experimentally induced puromycine aminonucleoside nephrosis (PAN) in rats: evaluation of angiogenic protein platelet-derived endothelial cell growth factor (PD-ECGF) expression in glomeruli
by: Seckin Ismail, et al.
Published: (2012-02-01)

Thrombosis of the Portal Venous System in Cirrhotic vs. Non-Cirrhotic Patients
by: Vania Cruz-Ramón, et al.
Published: (2018-05-01)

Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension
by: Nikolaj Worm Ørntoft, et al.
Published: (2021-06-01)